Table 2 Differences in clinical parameters by ABI and SMI subgroups in the Nagahama cohort

From: Clinical significance of an elevated ankle-brachial index differs depending on the amount of appendicular muscle mass: the J-SHIPP and Nagahama studies

 

Control

Elevated ABI

ABI quartiles

Q1–Q3

Q4

Q4

SMI quartiles

Q1–Q3

Q1–Q3

Q4

 

(5917)

(1504)

(618)

 

Mean ± SD

Mean ± SD

p

Mean ± SD

p

Age (years)

58.0 ± 13.2

60.8 ± 12.0

<0.001

57.0 ± 11.8

0.152

BMI (kg/m2)

22.1 ± 3.3

21.4 ± 2.4

<0.001

25.3 ± 3.2

<0.001

Brinkman index

150 ± 314

123 ± 277

0.005

138 ± 290

0.602

Systolic BP (mmHg)

125 ± 18

124 ± 17

0.205

127 ± 17

0.028

Diastolic BP (mmHg)

72 ± 11

71 ± 10

0.003

74 ± 11

<0.001

HDL cholesterol (mg/dl)

67 ± 17

69 ± 17

<0.001

62 ± 16

<0.001

LDL cholesterol (mg/dl)

118 ± 29

117 ± 28

0.214

118 ± 29

0.919

Triglyceride (mg/dl)

93 ± 60

89 ± 55

0.045

107 ± 81

<0.001

Glucose (mg/dl)

88 ± 14

88 ± 15

0.215

90 ± 14

<0.001

HbA1c (%)

5.6 ± 0.5

5.6 ± 0.5

0.658

5.7 ± 0.5

<0.001

HOMA-IR

0.87 ± 1.03

0.83 ± 1.13

0.367

1.09 ± 0.99

<0.001

CRP (μg/ml)

0.98 ± 3.78

0.88 ± 2.53

0.601

1.11 ± 4.15

0.612

Carotid IMT (mm)

0.70 ± 0.17

0.70 ± 0.16

0.214

0.71 ± 0.15

0.376

  1. Values are mean ± standard deviation
  2. Study participants were subdivided by quartiles of ankle-brachial index and high skeletal muscle index. The quartiles were defined by each sex separately: ABI: men, ≥1.16, women, ≥1.14; SMI: men, ≥8.14, women, ≥6.56. P values reached statistical significance are shown in bold
  3. Differences in clinical parameters with the control group were assessed by Dunnett’s test
Back to article page